|
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.
|
Aug 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Identification of Gene Expression-Based Prognostic Markers in the Hematopoietic Stem Cells of Patients With Myelodysplastic Syndromes.
|
Sep 2013
|
J Clin Oncol
|
myelodysplastic syndromes (MDS)
|
|
Epidemiology and risk factors for infections in myelodysplastic syndromes.
|
Sep 2013
|
Transpl Infect Dis
|
myelodysplastic syndromes (MDS)
|
|
Blood consult: paroxysmal nocturnal hemoglobinuria and its complications.
|
Sep 2013
|
Blood
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes.
|
Sep 2013
|
Ann Hematol
|
myelodysplastic syndromes (MDS)
|
|
Clinical and biological implications of driver mutations in myelodysplastic syndromes.
|
Sep 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Polymorphism of the complement receptor 1 gene correlates with hematological response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria
|
Sep 2013
|
Haematologica
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Prognostic factors and risk models in myelodysplastic syndromes
|
Sep 2013
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
|
Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes
|
Sep 2013
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
|
The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
|
Sep 2013
|
Adv Biol Regul
|
myelodysplastic syndromes (MDS)
|
